ATS 2019 Virtual Final Program

113 Direct Comparison Between Pathological Diagnosis of Cryobiopsy and Surgical Lung Biopsy for Interstitial Lung Disease/ T. Baba, T. Takemura, K. Okudela, M. Asaoka, T. Katano, G. Matama, N. Aiko, K. Isomoto, Y. Horio, Y. Uchida, R. Otoshi, E. Tabata, R. Shintani, H. Okabayashi, S. Ikeda, T. Niwa, T. Oda, R. Okuda, A. Sekine, H. Kitamura, S. Komatsu, E. Hagiwara, T. Ogura, , p.A4320 114 Polarization Sensitive Optical Coherence Tomography for In Vivo Microscopic Detection of Pulmonary Fibrosis/ L.P. Hariri, D.C. Adams, B.W. Roop, A. Muniappan, C. Keyes, J.C. Wain, C.R. Morse, M. Lanuti, A. Sharma, T.V. Colby, M. Mino-Kenudson, E.J. Mark, R.L. Kradin, L. Liang, D. Davies, M.V. Szabari, A.M. Tager, M.J. Suter, Boston, MA, p.A4321 115 Identification of Indoor Fungal Antigens in Assessment of Hypersensitivity Pneumonitis - an Alternate Approach/ F. Hernandez-Gonzalez, M.A. Calvo, A. Leonardo, M. Sanchez, M. Benegas, J. Ramirez, C.M. Lucena, C. Agusti, M. Boada, R. Castellanos, S.C. Rodriguez-Garcia, I. Bobolea, E. Arismendi, M. Pascal, O. Viñas, E. Ruiz, S. Prieto-Gonzalez, G. Espinosa, S. Cuerpo, p.A4322 116 Standard Panels, Environmental Samples, and Hypersensitivity Pneumonitis - Identification of the Elusive ‘Causal Antigen’/ M.L. Millerick-May, M. Mulks, J. Gerlach, J. Walton, J. Gardiner, K.D. Rosenman, East Lansing, MI, p.A4323 117 Adherence to Guidelines for Diagnosis and Management of Idiopathic Pulmonary Fibrosis Among Non-Academic Pulmonologists/ J.A. De Andrade, B. Stofan, T. Luckhardt, T. Kulkarni, P. Acosta Lara, S. Gulati, R. O’Beirne, Birmingham, AL, p.A4324 118 Peripheral Blood Proteomic Profiling to Distinguish Disease Biomarkers in the Multicenter IPF-PRO Registry Cohort/ J.L. Todd, K. Durham, R. Overton, M. Neely, J.A. Belperio, M. Gulati, H.J. Huang, J. Roman, L.K. Newby, I. Noth, R. Vinisko, Y. Liu, C. Hesslinger, T. Leonard, K.R. Flaherty, S.M. Palmer, Durham, NC, p.A4325 119 Usefulness of New Criteria for Chronic Hypersensitivity Pneumonitis Established by Delphi Method/ R. Takei, Y. Yamano, K. Kataoka, T. Yokoyama, T. Matsuda, T. Kimura, T. Johkoh, J. Fukuoka, Y. Kondoh, Seto, Japan, p.A4326 120 Radiological Fibrosis Score Predicts Bronchoalveolar Lavage Lymphocytosis in Fibrosing Lung Disease/ J. Barnett, P.L. Molyneaux, B. Rawal, A. Nair, A.U. Wells, T.M. Maher, A. Devaraj, London, United Kingdom, p.A4327 121 Diagnostic Delays in Interstitial Lung Diseases (ILDs)/ M. Wijsenbeek, N. Deparis, C. Valenzuela, L. Orsatti, B. Mounir, S.K. Danoff, Rotterdam, Netherlands, p.A4328 CLINICAL POSTER DISCUSSION SESSION C23 PLEURAL DISEASE, CF, AND OTHER MAGICAL CREATURES 9:15 a.m. - 11:15 a.m. OMNI DALLAS DOWNTOWN Dallas Ballroom E-F (Level 3) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 Chairing: A.C. Chee MD, Boston, MA G. Hong, MD, MHS, Philadelphia, PA H.E. Davies, MD, FRCP, Cardiff, United Kingdom 801 Is There a Gender “Gap” in the Response to Ivacaftor in Cystic Fibrosis Patients?/ K.E. Secunda, B.D. Jovanovic, S.M. Rowe, S.L. Heltshe, M. Jain, Chicago, IL, p.A4329 802 Neurocognitive Side Effects Thwart Transition to Tezacaftor/Ivacaftor CFTR Modulator Therapy in Patients with F508del Homozygous Cystic Fibrosis/ A. Perez, I.-S.V. Jue, D. Dawson, M.E. Kleinhenz, San Francisco, CA, p.A4330 803 Maternal Outcomes in Pregnant Women with Cystic Fibrosis/ K. Montemayor, C.R. Franklin, R. Dezube, N. Lechtzin, J.S. Sheffield, N.E. West, Baltimore, MD, p.A4331 804 Palliative Care for Adults with Cystic Fibrosis: A Systematic Review/ M. Marmor, A. Jonas, E. Rad, A. Mirza, R. Aslakson, Stanford, CA, p.A4332 805 Attitudes of Cystic Fibrosis Patients Towards Lung Transplant/ Z. Weintraub, M.J. Stephen, Philadelphia, PA, p.A4333 806 A Computational Model of Mechanical Ventilator Waveforms and CT Modeling to Detect Endotracheal Tube Narrowing from Mucous/ B.T. Kuhn, J. McCay, G. Rehm, M. Kadoch, S. Murin, J.Y. Adams, J. Delplanque, Sacramento, CA, p.A4334 807 Radiographic Pulmonary Vascular Determinants of Lung Function in the Framingham Heart Study/ A. Synn, G.R. Washko, R. San Jose Estepar, G.T. O’Connor, W. Li, M.A. Mittleman, M.B. Rice, Boston, MA, p.A4335 808 Mean Curvature of Isophotes: A Novel Quantitative CT Metric with Improved Discrimination Between Early COPD and Healthy Subjects/ P. Savadjiev, B. Gallix, D.H. Eidelman, R.J. Dandurand, Montreal, Canada, p.A4336 809 Age Is Not Associated with Six-Minute Walk Distance in Healthy Adults Aged 18 - 50/ S.J. Halliday, C. Yu, I.M. Robbins, J.H. Newman, E.L. Brittain, A.R. Hemnes, Nashville, TN, p.A4337 810 Using a Novel Digital Pleural Drainage Device: A Proof of Concept/ D. Thakkar, C.R. Lamb, S.M. Quadri, Burlington, MA, p.A4338 811 Lung Expandability Poorly Predicts Pleural Physiology: Introducing the Concept of Visceral Pleural Recoil in the Setting of Radiographic Lung Expansion/ R.J. Lentz, J. Pannu, M. Aboudara, C. Walston, O.B. Rickman, D.J. Feller-Kopman, L. Roller, F. Maldonado, Nashville, TN, p.A4339 812 Use of Tunneled Pleural Catheter for Hepatic Hydrothorax: A Systematic Review/ B.D. Salguero, A. Shujaat, New York, NY, p.A4340 813 Pleural Effusion Outcomes in Intensive Care: Analysis of a Large Clinical Database/ M. Bateman, T. John, M. Parikh, A. Alkhatib, F. Kheir, New Orleans, LA, p.A4341 814 Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema/ S. Idell, L.E.L. Beckert, B. Brockway, G. Simpson, A.M. Southcott, Y.C.G. Lee, N.M. Rahman, R.W. Light, S. Shoemaker, J.D. Gillies, A.A. Komissarov, G. Florova, K. Sarva, Tyler, TX, p.A4342 ATS 2019 • Dallas, TX 232 TUESDAY • MAY 21